Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Mustafa Modiwala, Tarang Jadav, Amit Kumar Sahu, Rakesh K. Tekade & Pinaki Sengupta. (2022) A Critical Review on Advancement in Analytical Strategies for the Quantification of Clinically Relevant Biological Transporters. Critical Reviews in Analytical Chemistry 52:7, pages 1557-1571.
Read now
Read now
Rui-Feng Liang, Wen-Jing Ge, Xian-Mei Song, Jun-Ping Zhang, Wei-Feng Cui, She-Feng Zhang & Geng-Sheng Li. (2020) Involvement of organic anion-transporting polypeptides and organic cation transporter in the hepatic uptake of jatrorrhizine. Xenobiotica 50:4, pages 479-487.
Read now
Read now
Guangyi Yang, Shufan Ge, Rashim Singh, Sumit Basu, Katherine Shatzer, Ming Zen, Jiong Liu, Yifan Tu, Chenning Zhang, Jinbao Wei, Jian Shi, Lijun Zhu, Zhongqiu Liu, Yuan Wang, Song Gao & Ming Hu. (2017) Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metabolism Reviews 49:2, pages 105-138.
Read now
Read now
Manuela de Lima Toccafondo Vieira & Carlos Alberto Tagliati. (2014) Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 581-597.
Read now
Read now
William J. Chiou, Sonia M. de Morais, Ryota Kikuchi, Richard L. Voorman, Xiaofeng Li & Daniel A. J. Bow. (2014) In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. Xenobiotica 44:3, pages 276-282.
Read now
Read now
David A Powell. (2014) An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 – 2013). Expert Opinion on Therapeutic Patents 24:2, pages 155-175.
Read now
Read now
Hugh A Barton, Yurong Lai, Theunis C Goosen, Hannah M Jones, Ayman F El-Kattan, James R Gosset, Jian Lin & Manthena V Varma. (2013) Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond. Expert Opinion on Drug Metabolism & Toxicology 9:4, pages 459-472.
Read now
Read now
Alexander M Cressman, Vanja Petrovic & Micheline Piquette-Miller. (2012) Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Review of Clinical Pharmacology 5:1, pages 69-89.
Read now
Read now
Bruno Stieger & Andreas Geier. (2011) Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opinion on Drug Metabolism & Toxicology 7:4, pages 411-425.
Read now
Read now
Articles from other publishers (77)
Delphine Fessart & Jacques Robert. (2023) Mécanismes de résistance aux traitements des cancers. Bulletin du Cancer.
Crossref
Crossref
Aiyu Peng, Chunmei Gong, Yuanfei Xu, Xiongshun Liang, Xiaoping Chen, Wenxu Hong & Junxia Yan. (2023) Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis. Frontiers in Public Health 11.
Crossref
Crossref
Bastian Haberkorn, Stefan Oswald, Niklas Kehl, Arne Gessner, R. Verena Taudte, Jan Philipp Dobert, Friederike Zunke, Martin F. Fromm & Jörg König. (2022) Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors. Molecular Pharmacology 102:6, pages 248-258.
Crossref
Crossref
Min-Chang Kim & Young-Joo Lee. (2022) Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 14:12, pages 2562.
Crossref
Crossref
Johanna Huttunen, Santosh Kumar Adla, Magdalena Markowicz-Piasecka & Kristiina M. Huttunen. (2022) Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). Pharmaceutics 14:6, pages 1234.
Crossref
Crossref
Haiting Ma, Esmée de Zwaan, Yang Eric Guo, Paloma Cejas, Prathapan Thiru, Martijn van de Bunt, Jacob F. Jeppesen, Sudeepa Syamala, Alessandra Dall’Agnese, Brian J. Abraham, Dongdong Fu, Carrie Garrett-Engele, Tong Ihn Lee, Henry W. Long, Linda G. Griffith, Richard A. Young & Rudolf Jaenisch. (2022) The nuclear receptor THRB facilitates differentiation of human PSCs into more mature hepatocytes. Cell Stem Cell 29:5, pages 795-809.e11.
Crossref
Crossref
Houwaida Abbes, Sana Boujaafar, Marwa Ajmi, Asma Omezzine & Ali Bouslama. (2022) Apport de la pharmacogénétique dans le domaine cardio-vasculaire, l’exemple des statines. Actualités Pharmaceutiques 61:616, pages 31-36.
Crossref
Crossref
Manthena V. S. Varma, Ayman El‐Kattan & Yurong Lai. 2022. Drug Transporters. Drug Transporters
433
452
.
Yifan Tu, Lu Wang, Yi Rong, Vincent Tam, Taijun Yin, Song Gao, Rashim Singh & Ming Hu. (2021) Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats. eLife 10.
Crossref
Crossref
Nadia A. Thabet, Dalia El‐Khouly, Mohamed M. Sayed‐Ahmed & Mervat M. Omran. (2021) Thymoquinone chemosensitizes human colorectal cancer cells to imatinib via uptake/efflux genes modulation. Clinical and Experimental Pharmacology and Physiology 48:6, pages 911-920.
Crossref
Crossref
Anne T. Nies, Jörg König, Ute Hofmann, Charlotte Kölz, Martin F. Fromm & Matthias Schwab. (2021) Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters. Pharmaceutics 13:3, pages 369.
Crossref
Crossref
Nihan Izat & Selma Sahin. (2021) Hepatic transporter‐mediated pharmacokinetic drug–drug interactions: Recent studies and regulatory recommendations. Biopharmaceutics & Drug Disposition 42:2-3, pages 45-77.
Crossref
Crossref
Henriette E. Meyer zu Schwabedissen, Isabell Seibert, Markus Grube, Claudio L. Alter, Werner Siegmund & Janine Hussner. (2020) Genetic variants of SLCO1B7 are of relevance for the transport function of OATP1B3-1B7. Pharmacological Research 161, pages 105155.
Crossref
Crossref
Wesley Wei Wang, Leandro Gallo, Appaso Jadhav, Richard Hawkins & Christopher G. Parker. (2019) The Druggability of Solute Carriers. Journal of Medicinal Chemistry 63:8, pages 3834-3867.
Crossref
Crossref
Anurag T. K. Baidya, Kalyan Ghosh, Sk. Abdul Amin, Nilanjan Adhikari, Jayabalan Nirmal, Tarun Jha & Shovanlal Gayen. (2020)
In silico
modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2
. New Journal of Chemistry 44:10, pages 4129-4143.
Crossref
Crossref
Natalia Khuri & Shantanu Deshmukh. (2018) Machine Learning for Classification of Inhibitors of Hepatic Drug Transporters. Machine Learning for Classification of Inhibitors of Hepatic Drug Transporters.
Gwendolyn A. McMillin, Mia Wadelius & Victoria M. Pratt. 2018. Principles and Applications of Molecular Diagnostics. Principles and Applications of Molecular Diagnostics
295
327
.
Obinna N. Obianom, Ana L. Coutinho, Wei Yang, Hong Yang, Fengtian Xue & Yan Shu. (2017) Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2. Molecular Pharmaceutics 14:8, pages 2726-2739.
Crossref
Crossref
Abdullah Mayati, Amélie Moreau, Claire Denizot, Bruno Stieger, Yannick Parmentier & Olivier Fardel. (2017) β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine. European Journal of Pharmaceutical Sciences 106, pages 302-312.
Crossref
Crossref
Mohamad Shebley, Jinrong Liu, Olga Kavetskaia, Jens Sydor, Sonia M. de Morais, Volker Fischer, Marjoleen J.M.A. Nijsen & Daniel A.J. Bow. (2017) Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir. Drug Metabolism and Disposition 45:7, pages 755-764.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Yogita A. Ghodke-Puranik & Jatinder K. Lamba. 2017. Innovative Approaches in Drug Discovery. Innovative Approaches in Drug Discovery
195
234
.
Moritz Gruetz, Heinrich Sticht, Hartmut Glaeser, Martin F. Fromm & Jörg König. (2016) Analysis of amino acid residues in the predicted transmembrane pore influencing transport kinetics of the hepatic drug transporter organic anion transporting polypeptide 1B1 (OATP1B1). Biochimica et Biophysica Acta (BBA) - Biomembranes 1858:11, pages 2894-2902.
Crossref
Crossref
Hiroyuki Sasabe, Yoshihiko Shimokawa, Masakazu Shibata, Kenta Hashizume, Yusuke Hamasako, Yoshihiro Ohzone, Eiji Kashiyama & Ken Umehara. (2016) Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters. Antimicrobial Agents and Chemotherapy 60:6, pages 3497-3508.
Crossref
Crossref
Hwan You, Kyungro Lee, Sangwon Lee, Sung Bo Hwang, Kwang-Yon Kim, Kwang-Hwi Cho & Kyoung Tai No. (2015) Computational classification models for predicting the interaction of compounds with hepatic organic ion importers. Drug Metabolism and Pharmacokinetics 30:5, pages 347-351.
Crossref
Crossref
Albert P. Li. (2015)
Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOC
TM
) System
. Toxicological Research 31:2, pages 137-149.
Crossref
Crossref
Bruno Stieger & Gerd A. Kullak‐Ublick. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
159
172
.
Sieto Bosgra, Evita van de Steeg, Maria L. Vlaming, Kitty C. Verhoeckx, Maarten T. Huisman, Miriam Verwei & Heleen M. Wortelboer. (2014) Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. European Journal of Pharmaceutical Sciences 65, pages 156-166.
Crossref
Crossref
Douglas B. Kell & Stephen G. Oliver. (2014) How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Frontiers in Pharmacology 5.
Crossref
Crossref
Wei-Yu Hou, Shang-Fu Xu, Qiong-Ni Zhu, Yuan-Fu Lu, Xing-Guo Cheng & Jie Liu. (2014) Age- and sex-related differences of organic anion-transporting polypeptide gene expression in livers of rats. Toxicology and Applied Pharmacology 280:2, pages 370-377.
Crossref
Crossref
Ayman El‐Kattan, Manthena V. Varma & Yurong Lai. 2014. Drug Transporters. Drug Transporters
371
387
.
Rui Li, Hugh A. Barton & Manthena V. Varma. (2014) Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved. Clinical Pharmacokinetics 53:8, pages 659-678.
Crossref
Crossref
Verena Gotta, Stephane Bouchet, Nicolas Widmer, Peter Schuld, Laurent A. Decosterd, Thierry Buclin, Francois-Xavier Mahon, Chantal Csajka & Mathieu Molimard. (2014) Large-scale imatinib dose–concentration–effect study in CML patients under routine care conditions. Leukemia Research 38:7, pages 764-772.
Crossref
Crossref
Catherine M. Pastor, Beat Müllhaupt & Bruno Stieger. (2014) The Role of Organic Anion Transporters in Diagnosing Liver Diseases by Magnetic Resonance Imaging. Drug Metabolism and Disposition 42:4, pages 675-684.
Crossref
Crossref
Albert P Li. (2014) Biomarkers and human hepatocytes. Biomarkers in Medicine 8:2, pages 173-183.
Crossref
Crossref
Varun Khurana, Mukul Minocha, Dhananjay Pal & Ashim K. Mitra. (2014) Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions 29:4.
Crossref
Crossref
Varun Khurana, Mukul Minocha, Dhananjay Pal & Ashim K. Mitra. (2014) Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions 29:3.
Crossref
Crossref
Fei Xu, Zhen Li, Jian Zheng, Florence Shin Gee Cheung, Ting Chan, Ling Zhu, Hongxiang Zhuge & Fanfan Zhou. (2013) The Inhibitory Effects of the Bioactive Components Isolated from Scutellaria Baicalensis on the Cellular Uptake Mediated by the Essential Solute Carrier Transporters. Journal of Pharmaceutical Sciences 102:11, pages 4205-4211.
Crossref
Crossref
Jose L. Ulloa, Simone Stahl, James Yates, Neil Woodhouse, J. Gerry Kenna, Huw B. Jones, John C. Waterton & Paul D. Hockings. (2013) Assessment of gadoxetate DCE‐MRI as a biomarker of hepatobiliary transporter inhibition. NMR in Biomedicine 26:10, pages 1258-1270.
Crossref
Crossref
Katrina L. Mealey. (2013) Adverse Drug Reactions in Veterinary Patients Associated with Drug Transporters. Veterinary Clinics of North America: Small Animal Practice 43:5, pages 1067-1078.
Crossref
Crossref
Youssef Daali, Philippe Millet, Pierre Dayer & Catherine M. Pastor. (2013) Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs. Drug Metabolism and Disposition 41:8, pages 1548-1556.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Jörg König, Fabian Müller & Martin F. Fromm. (2013) Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects. Pharmacological Reviews 65:3, pages 944-966.
Crossref
Crossref
Victoria C. Ziesenitz, Sonja K. König, Nina Mahlke, Ricarda Jantos, Gisela Skopp, Johanna Weiss, Walter E. Haefeli & Gerd Mikus. (2013) Fentanyl Pharmacokinetics is not Dependent on Hepatic Uptake by Organic Anion‐Transporting Polypeptide 1B1 in Human Beings. Basic & Clinical Pharmacology & Toxicology 113:1, pages 43-48.
Crossref
Crossref
Sabine Klatt, Martin F. Fromm & Jörg König. (2012)
The Influence of Oral Antidiabetic Drugs on Cellular Drug Uptake Mediated by Hepatic
OATP
Family Members
. Basic & Clinical Pharmacology & Toxicology 112:4, pages 244-250.
Crossref
Crossref
Kazuya Maeda & Yuichi Sugiyama. (2013) Transporter biology in drug approval: Regulatory aspects. Molecular Aspects of Medicine 34:2-3, pages 711-718.
Crossref
Crossref
Bruno Hagenbuch & Bruno Stieger. (2013) The SLCO (former SLC21) superfamily of transporters. Molecular Aspects of Medicine 34:2-3, pages 396-412.
Crossref
Crossref
Jörg König & Martin F. Fromm. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters
141
169
.
Lei Zhang, Gilbert J. Burckart, Lawrence J. Lesko & Shiew‐Mei Huang. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters
39
71
.
E. van de Steeg, R. Greupink, M. Schreurs, I.H.G. Nooijen, K.C.M. Verhoeckx, R. Hanemaaijer, D. Ripken, M. Monshouwer, M.L.H. Vlaming, J. DeGroot, M. Verwei, F.G.M. Russel, M.T. Huisman & H.M. Wortelboer. (2013) Drug-Drug Interactions between Rosuvastatin and Oral Antidiabetic Drugs Occurring at the Level of OATP1B1. Drug Metabolism and Disposition 41:3, pages 592-601.
Crossref
Crossref
Douglas B. Kell, Paul D. Dobson, Elizabeth Bilsland & Stephen G. Oliver. (2013) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discovery Today 18:5-6, pages 218-239.
Crossref
Crossref
Hyewon Jeon, In-Jin Jang, SeungHwan Lee, Kyoichi Ohashi, Tsutomu Kotegawa, Ichiro Ieiri, Joo-Youn Cho, Seo Hyun Yoon, Sang-Goo Shin, Kyung-Sang Yu & Kyoung Soo Lim. (2013) Apple juice greatly reduces systemic exposure to atenolol. British Journal of Clinical Pharmacology 75:1, pages 172-179.
Crossref
Crossref
Oliver Zolk, Rebecca Schnepf, Marc Muschler, Martin F. Fromm, Olaf Wendler, Maximilian Traxdorf, Heinrich Iro & Johannes Zenk. (2013) Transporter Gene Expression in Human Head and Neck Squamous Cell Carcinoma and Associated Epigenetic Regulatory Mechanisms. The American Journal of Pathology 182:1, pages 234-243.
Crossref
Crossref
Alexander V. LyubimovKazuya Maeda & Yuichi Sugiyama. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
32
.
Peng Li, Michael Weiss & Michael S. Roberts. (2012) Hepatic interaction between quinidine and digoxin: Role of inhibition of sinusoidal Na+/K+ ATPase digoxin binding. European Journal of Pharmaceutical Sciences 47:2, pages 506-511.
Crossref
Crossref
Manthena V. S. Varma, George Chang, Yurong Lai, Bo Feng, Ayman F. El-Kattan, John Litchfield & Theunis C. Goosen. (2012) Physicochemical Property Space of Hepatobiliary Transport and Computational Models for Predicting Rat Biliary Excretion. Drug Metabolism and Disposition 40:8, pages 1527-1537.
Crossref
Crossref
Jörg König, Sabine Klatt, Karin Dilger & Martin F. Fromm. (2012)
Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters
OATP
1B1,
OATP
1B3,
OATP
2B1 and
NTCP
. Basic & Clinical Pharmacology & Toxicology 111:2, pages 81-86.
Crossref
Crossref
Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen & Janne T. Backman. (2012) Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends in Pharmacological Sciences 33:6, pages 312-322.
Crossref
Crossref
J Wang, T P Hughes, C H Kok, V A Saunders, A Frede, K Groot-Obbink, M Osborn, A A Somogyi, R J D'Andrea & D L White. (2012) Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells. British Journal of Cancer 106:11, pages 1772-1778.
Crossref
Crossref
Imad Hanna & Ryan M. Pelis. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
29
54
.
Megan Roth, Amanda Obaidat & Bruno Hagenbuch. (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. British Journal of Pharmacology 165:5, pages 1260-1287.
Crossref
Crossref
C Fahrmayr, J König, D Auge, M Mieth & MF Fromm. (2012) Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple‐transfected MDCK‐OATP1B1‐UGT1A1‐MRP2 cells. British Journal of Pharmacology 165:6, pages 1836-1847.
Crossref
Crossref
Katalin Jemnitz, Zsuzsa Veres, Monika Szabo, Zsolt Baranyai, Ferenc Jakab & Laszlo Vereczkey. (2012) Differential inhibitory effect of cyclosporin A and bosentan on taurocholate uptake in human and rat hepatocytes as a function of culturing time. Toxicology in Vitro 26:1, pages 174-181.
Crossref
Crossref
Dilek Iusuf, Evita van de Steeg & Alfred H. Schinkel. (2012) Functions of OATP1A and 1B transporters in vivo: insights from mouse models. Trends in Pharmacological Sciences 33:2, pages 100-108.
Crossref
Crossref
C. Yan Cheng & Dolores D. Mruk. (2012) The Blood-Testis Barrier and Its Implications for Male Contraception. Pharmacological Reviews 64:1, pages 16-64.
Crossref
Crossref
K Mandery, H Glaeser & MF Fromm. (2011) Interaction of innovative small molecule drugs used for cancer therapy with drug transporters. British Journal of Pharmacology 165:2, pages 345-362.
Crossref
Crossref
Joseph A. Ware, Lei Zhang & Shiew-Mei Huang. 2012. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology
217
237
.
David A. Powell, W. Cameron Black, Kelly Bleasby, Chi-Chung Chan, Denis Deschenes, Marc Gagnon, Rob Gordon, Jocelyne Guay, Sebastien Guiral, Michael J. Hafey, Zheng Huang, Elise Isabel, Yves Leblanc, Angela Styhler, Li-Jing Xu, Lei Zhang & Renata M. Oballa. (2011) Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters 21:24, pages 7281-7286.
Crossref
Crossref
Maria Ulvestad, Petter Björquist, Espen Molden, Anders Åsberg & Tommy B. Andersson. (2011) OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. Biochemical Pharmacology 82:9, pages 1219-1226.
Crossref
Crossref
Eleni Aklillu, Sabina Mugusi, Eliford Ngaimisi, Michael Marcus Hoffmann, Sonja K?nig, Victoria Ziesenitz, Gerd Mikus, Walter Emil Haefeli & Johanna Weiss. (2011) Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler?-based method. European Journal of Clinical Pharmacology 67:11, pages 1139-1145.
Crossref
Crossref
Sabine Klatt, Martin F. Fromm & Jörg König. (2011) Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs. Pharmaceutics 3:4, pages 680-705.
Crossref
Crossref
Juergen Kindla, Fabian Müller, Maren Mieth, Martin F. Fromm & Jörg König. (2011) Influence of Non-Steroidal Anti-Inflammatory Drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-Mediated Drug Transport. Drug Metabolism and Disposition 39:6, pages 1047-1053.
Crossref
Crossref
Jörg König, Hartmut Glaeser, Markus Keiser, Kathrin Mandery, Ulrich Klotz & Martin F. Fromm. (2011) Role of Organic Anion-Transporting Polypeptides for Cellular Mesalazine (5-Aminosalicylic Acid) Uptake. Drug Metabolism and Disposition 39:6, pages 1097-1102.
Crossref
Crossref
O Zolk & M F Fromm. (2011) Transporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions. Clinical Pharmacology & Therapeutics 89:6, pages 798-805.
Crossref
Crossref
Bruno Stieger & Peter J Meier. (2011) Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 12:5, pages 611-631.
Crossref
Crossref
M K DeGorter & R B Kim. (2011) Use of Transgenic and Knockout Mouse Models to Assess Solute Carrier Transporter Function. Clinical Pharmacology & Therapeutics 89:4, pages 612-616.
Crossref
Crossref
Mikko Niemi, Marja K. Pasanen & Pertti J. Neuvonen. (2011) Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake. Pharmacological Reviews 63:1, pages 157-181.
Crossref
Crossref